Researchers have suggested that more intense assessments for cardiovascular interventions and more aggressive strategies for prevention of primary cardiovascular disease may be needed for patients with concurrent hypertension and psoriasis than general hypertension patients.
It comes as new research suggests that patients with psoriasis and hypertension may experience earlier and more aggressive disease progression compared with general hypertensive patients.
Researchers examined data on 8,078 hypertensive patients from the Taiwan National Health Insurance Research Database, of which 4,039 had psoriasis and 4,039 did not, to investigate whether patients with psoriasis and hypertension have a higher requirement for cardiovascular procedures and surgery than those without the condition. The mean follow-up period for the overall study was 5.62 years
They found psoriasis was associated with an increased risk for cardiovascular procedure and surgery in patients with hypertension (adjusted hazard ratio [aHR] 1.28; 95% CI 1.07-1.53). Those with severe psoriasis or psoriatic arthritis had higher risks of cardiovascular procedure and surgery than patients with mild psoriasis (aHR 1.22; 95% CI 0.98-1.51) or patients without psoriatic arthritis (aHR 1.15; 95% CI 0.84-1.58), respectively, however the differences were not statistically significant.
The findings are published in the Journal of Dermatology.